Phase not reported / not applicableExpanded access availableEXPANDED ACCESS
An Intermediate Size Expanded Access Protocol of Elamipretide
ClinicalTrials.gov · NCT04689360 · Registry updated: 2026-10-27
- Condition / research focus
- Mitochondrial Diseases; Barth Syndrome
- Sponsor
- Stealth BioTherapeutics Inc.
- Countries with listed sites
- No country reported
- Registry dates and results
- Start: Not reported. Completion: Not reported (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- elamipretide (drug) — also listed as: MTP-131
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.